Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Endophthalmitis caused by Phialophora verrucosa: A case report and literature re...
Información de la revista
Vol. 30. Núm. 3.
Páginas 163-165 (Marzo 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. 3.
Páginas 163-165 (Marzo 2012)
Cartas científicas
Acceso a texto completo
Endophthalmitis caused by Phialophora verrucosa: A case report and literature review of Phialophora ocular infections
Endoftalmitis causada por Phialophora verrucosa: descripción de un caso y revisión de la literatura sobre infecciones oculares por Phialophora
Visitas
5194
M. Isolina Campos-Herreroa,
Autor para correspondencia
mcamnavl@gobiernodecanarias.org

Corresponding author.
, Luis Tandónb, Iballa Horcajadaa, Francisco Medina-Riverob
a Servicio de Microbiología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
b Servicio de Oftalmología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Ocular infections caused by Phialophora spp. including the present case.
Texto completo
Dear Editor,

We present a case of endophthalmitis caused by Phialophora verrucosa and review the available literature on Phialophora ocular infections.

A 66-year-old man with hypertension, type II diabetes mellitus and bilateral chronic glaucoma consulted the Ophthalmology Department about his red right eye. The patient did not report any previous eye surgery or recent ocular trauma. Episcleritis was diagnosed and he was started on topical corticosteroids and antibiotics. Six months later, he complained about loss of vision, and ophthalmic examination showed a fine brown material in the anterior chamber. Material aspirate and aqueous tumor were sent to the Microbiology and Pathology laboratories. Histological examination showed septate hyphae and fungal spores. After a week on Sabouraud dextrose agar, the material from both samples became black, embedded in the medium, and increased its size. On potato dextrose agar, the colony was initially white and turned to black with a black reverse. Microscopically, hyphae were septate, brown and branched, phialides were flask shaped with a cup-like collarette and ellipsoidal conidia accumulated at the apice of the phialide. All characteristics corresponded to the Phialophora genus. The strain was sent to a reference laboratory where it was identified as P. verrucosa by morphological criteria and PCR and sequencing using ITS1 and ITS4 primers, and antifungal susceptibility testing was made according to EUCAST methodology. A MIC less than or equal to 0.5mg/L was obtained for amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin. The patient was started on oral voriconazole (200mg every 12h), amphotericin B eye drops (every 6h) and topical corticosteroid, with no improvement. Vitrectomy and intravitreal amphotericin B injection (5μg) were performed twice and new samples were taken. Finally, the patient underwent enucleation of the eye due to recurrent pain and blindness. Currently, he is asymptomatic.

There are seven reported cases of ocular infections caused by Phialophora species1–8 (Table 1). Data were not available for one patient. All the remaining patients were men, with a mean age of 52.3 years. The most frequent risk factors were trauma, occurred between days and months before the first ophthalmologic consultation, and treatment with topical corticosteroids. In our case, the patient reported a trauma with a piece of wood thirty five years before, with recurrent episodes of hyperemia during the last few years. As regards the clinical presentation of the infection, six patients had keratitis, and two had endophthalmitis. All patients were initially treated with topical and/or oral antifungals, most of them unsuccessfully. Surgery was required in six patients, keratoplasty in four and vitrectomy in two, followed by intraocular and/or intravenous antifungal therapy in four of them. More than one antifungal agent was used in five cases, and amphotericin B was the most commonly prescribed drug. Due to clinical progression of the infection, the eye was enucleated in three cases. The outcome of the rest of patients was good.

Table 1.

Ocular infections caused by Phialophora spp. including the present case.

Species (case)  Year of publication (Reference)  Fungal identification procedure  Type of ocular infection  Age/sex  Risk factors  Ocular symptoms and signs  Antifungal therapy  Surgery  Outcome 
P. verrucosa (1)  1966 (1,2)  Morphological identification  Keratitis  47/M  Trauma.Topical steroids  Discomfort, hyperemia, photophobia  AMB (TOP), TBZ (TOP)  Keratoplasty twice  Cured 
P. verrucosa (2) (+C. cladosporioides1976 (3)  Morphological identification  Keratitis  56/M  Trauma.Topical steroids  Persistent ocular inflammation, loss of vision. Hypopyon  NTM (TOP)  Keratoplasty twice  Cured 
P. bubakii (3)  1983 (4)  Morphological identification  Keratitis  34/M  Trauma  Hypopyon  FCT (TOP)  None  Cured 
Phialophora sp. (4)  1995 (5)  NDA  Keratitis  34/M  Contact lenses use. Topical steroids  Discomfort, pain, photophobia, loss of vision  NTM (TOP), AMB (TOP+EV)  Keratoplasty  Cured 
P. verrucosa (5) (C. tropicalis, P. acnes2008 (6)  NDA  Keratitis  79/M  Trauma  Pain, loss of vision  AMB (TOP), KTZ (PO), VCZ (TOP, PO, IO), ITZ (PO)  Keratoplasty twice  Enucleation 
Phialophora sp. (6)  2010 (7)  Morphological identification  Keratitis  NDA  NDA  NDA  NDA  NDA  NDA 
P. verrucosa (7)  2010 (8)  Morphological identification.Sequencing  Endophthalmitis  50/M  Trauma  Loss of vision  AMB (IO), FC (IO, TOP), NTM (TOP)  Vitrectomy  Enucleation 
P. verrucosa (8)  Present report  Morphological identification.Sequencing  Endophthalmitis  66/M  Topical steroids  Pain, hyperemia, loss of vision  VCZ (PO), AMB (TOP, IO)  Vitrectomy twice  Enucleation 

AMB: amphotericin B; EV: endovenous; FC: fluconazole; FCT: flucytosine; IO: intraocular; ITZ: itraconazole; KTZ: ketoconazole; NDA: no data available; NTM: natamycin; PO: by mouth; TOP: topical; TBZ: thiabendazole; VCZ: voriconazole.

Fungal infections of the eye are mainly caused by Candida, Fusarium and Aspergillus species. Genus Phialophora, a dematiaceous fungus, is a rare agent of ocular infection; in fact, we have only found seven reported cases. Ocular trauma was the most common predisposing factor. In our patient, due to the long time passed since the trauma, we cannot assume it as the origin of the infection. More than half of the patients received corticosteroids that could facilitate the fungal infection and its progress. To reach the diagnosis of ocular fungal infections, a collection of appropriate specimens is mandatory: in keratitis, superficial scrapings or a corneal biopsy, and in endophthalmitis, aqueous and vitreous aspirates. A direct microscopic examination offers a rapid presumptive diagnosis and culture is essential to identify the fungus involved, and to determine the susceptibility profile of the strain. Since dematiaceous fungi are commonly found in the environment, their clinical significance needs to be assessed. In our case, histological examination and repeated cultures from several intraocular samples obtained at different times confirmed that P. verrucosa was the causative agent. Despite the lack of interpretative MIC breakpoints and limited correlation between MIC and treatment outcome, antifungal susceptibility testing is recommended, especially when the fungus is infrequently isolated. Phialophora is usually susceptible to amphotericin, itraconazole and voriconazole.9 In the management of aspergillus keratitis, the prompt initiation of antifungal therapy and surgery in refractory patients is recommended, and vitrectomy followed by intravitreal amphotericin B or intravitreal or systemic voriconazole in aspergillus endophthalmitis.10 Currently, there are no therapeutic recommendations for ocular infections caused by fungi other than Aspergillus.

In summary, although Phialophora is rarely involved in eye infections, its role as a potential pathogen should be kept in mind when it is isolated from ocular samples. Given the availability of antifungals, susceptibility testing of the strain is important to select the optimal therapy.

Acknowledgments

We thank Dr. Calixto Arias for his assistance in editing the manuscript. We also thank the Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, for the identification of the species and antifungal susceptibility of the strain.

References
[1]
L.A. Wilson, R.R. Sexton, D. Ahearn.
Keratochromomycosis.
Arch Ophthal, 76 (1966), pp. 811-816
[2]
D.B. Jones, R. Sexton, G. Rebell.
Mycotic keratitis in South Florida: a review of thirty-nine cases.
Trans Ophthalmol Soc UK, 89 (1969), pp. 781-797
[3]
F.M. Polack, C. Siverio, R.H. Bresky.
Corneal chromomycosis. Double infection by Phialophora verrucosa (Medlar) and Cladosporium cladosporiodes (Frescenius).
Ann Ophthalmol, 2 (1976), pp. 139-144
[4]
R.A. Eiferman, J.W. Snyder, J.V. Barbee.
Corneal chromomycosis.
Am J Ophthalmol, 95 (1983), pp. 255-256
[5]
L.W. Hirst, K. Stallard, M. Whitby, R. Perrin.
Phialophora corneal ulcer.
Aust N Z J Ophthalmol, 25 (1995), pp. 223-225
[6]
M. Banitt, A. Berenbom, M. Shah, D. Buxton, T. Milman.
A Case of polymicrobial keratitis violating an intact lens capsule.
Cornea, 27 (2008), pp. 1057-1061
[7]
V. Vanzzini Zago, P. Manzano-Gayosso, F. Hernández-Hernández, L.J. Méndez-Tovar, A. Gómez-Leal, R. López-Martinez.
Mycotic keratitis in an eye care hospital in México city [Queratomicosis en un centro de atención oftalmológica en la Ciudad de México].
Rev Iberoam Micol, 27 (2010), pp. 57-61
[8]
S. Sun, G. Yuan, G. Zhao, H. Chen, B. Yu.
Endophthalmitis caused by Phialophora verrucosa and Streptococcus intermedius: a case report.
Med Mycol, 48 (2010), pp. 1108-1111
[9]
G.S. Hoog, J. Guarro, J. Gené, M.J. Figueras.
Hyphomycetes: explanatory chapters, and keys to the genera.
Atlas of clinical fungi, 2nd ed., Centraalbureau voor Schimmelcultures and Universitat Rovira i Virgili, (2000),
[10]
T. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, K.A. Marr, et al.
Treatment of aspergillosis: clinical practice guidelines of the infectious diseases Society of America.
Clin Infect Dis, 46 (2008), pp. 327-360
Copyright © 2011. Elsevier España, S.L.. All rights reserved
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos